Jennifer Vidler

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Muñoz‐Ruiz et al. · The Lancet Oncology · 2021 · 612 citations · Full text

Veterinary Medicine, Immunology, Oncology +14

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19

Gavin D. Perkins, Chen Ji, Bronwen Connolly et al. · JAMA · 2022 · 414 citations · Full text

Medicine, Respiratory Therapy, Critical Care Respiratory Therapy +16

Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5‐year experience

Jennifer Vidler, Kate Gardner, Kenneth Amenyah et al. · British Journal of Haematology · 2015 · 127 citations · Full text

Medicine, Hematology, Immunology +17

Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients

Sultan Abdul-Jawad, Luca Baù, Thanussuyah Alaguthurai et al. · Cancer Cell · 2021 · 117 citations · Full text

Life Sciences, Immunology, Oncology +14